Stay updated on Isatuximab Combo in High-Risk Smoldering MM Clinical Trial

Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T23:15:42.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The Dec. 5, 2025 version of the study record now lists References among its changes. An NIH notice about the transition from “AI” to “SI” also appears at the top of the page.
    Difference
    0.5%
    Check dated 2026-10-24T23:17:04.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T23:34:50.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T23:31:36.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The history list now shows a newer revision tag, v3.7.0, replacing the previous v3.6.6 tag, indicating an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-09-19T22:17:54.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry v3.6.6, replacing the previous v3.6.5 entry in the revision list.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:11.000Z thumbnail image

Stay in the know with updates to Isatuximab Combo in High-Risk Smoldering MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.